Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
BRIACELL THERAP (BCTX) had Consolidated Net Income/Loss of $-7.24M for the most recently reported fiscal quarter, ending 2026-04-30.
| Income Statement Financials | |
-- |
|
$-7.16M |
|
-- |
|
-- |
|
$7.62M |
|
$-7.62M |
|
$0.38M |
|
$-7.24M |
|
$-7.24M |
|
$-7.24M |
|
$-7.24M |
|
|
Consolidated Net Income/Loss |
$-7.24M |
$-7.24M |
|
$-7.62M |
|
$-7.59M |
|
7.25M |
|
7.25M |
|
$-0.99 |
|
$-0.99 |
|
| Balance Sheet Financials | |
$25.39M |
|
$0.35M |
|
$1.68M |
|
$27.07M |
|
$3.59M |
|
-- |
|
$0.07M |
|
$3.66M |
|
$23.41M |
|
$23.24M |
|
$23.41M |
|
7.25M |
|
| Cash Flow Statement Financials | |
$-22.69M |
|
$-8.80M |
|
$27.87M |
|
$10.49M |
|
$6.88M |
|
$-3.61M |
|
$1.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.92% |
|
-31.15% |
|
-26.73% |
|
-30.92% |
|
$3.23 |
|
$-3.15 |
|
$-3.13 |
|